FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3141650554> ?p ?o ?g. }

• W3141650554 endingPage "e28094" @default.
• W3141650554 startingPage "e28094" @default.
• W3141650554 abstract "Background Tuberculosis (TB) is an urgent global health threat and the world’s deadliest infectious disease despite being largely curable. A critical challenge is to ensure that patients adhere to the full course of treatment to prevent the continued spread of the disease and development of drug-resistant disease. Mobile health interventions hold promise to provide the required adherence support to improve TB treatment outcomes. Objective This study aims to evaluate the effectiveness of the TB treatment support tools (TB-TSTs) intervention on treatment outcomes (success and default) and to assess patient and provider perceptions of the facilitators and barriers to TB-TSTs implementation. Methods The TB-TSTs study is an open-label, randomized controlled trial with 2 parallel groups in which 400 adult patients newly diagnosed with TB will be randomly assigned to receive usual care or usual care plus TB-TSTs. Participants will be recruited on a rolling basis from 4 clinical sites in Argentina. The intervention consists of a smartphone progressive web app, a treatment supporter (eg, TB nurse, physician, or social worker), and a direct adherence test strip engineered for home use. Intervention group participants will report treatment progress and interact with a treatment supporter using the app and metabolite urine test strip. The primary outcome will be treatment success. Secondary outcomes will include treatment default rates, self-reported adherence, technology use, and usability. We will assess patients’ and providers’ perceptions of barriers to implementation and synthesize lessons learned. We hypothesize that the TB-TSTs intervention will be more effective because it allows patients and TB supporters to monitor and address issues in real time and provide tailored support. We will share the results with stakeholders and policy makers. Results Enrollment began in November 2020, with a delayed start due to the COVID-19 pandemic, and complete enrollment is expected by approximately July 2022. Data collection and follow-up are expected to be completed 6 months after the last patient is enrolled. Results from the analyses based on the primary end points are expected to be submitted for publication within a year of data collection completion. Conclusions To our knowledge, this randomized controlled trial will be the first study to evaluate a patient-centered remote treatment support strategy using a mobile tool and a home-based direct drug metabolite test. The results will provide robust scientific evidence on the effectiveness, implementation, and adoption of mobile health tools. The findings have broader implications not only for TB adherence but also more generally for chronic disease management and will improve our understanding of how to support patients facing challenging treatment regimens. Trial Registration ClinicalTrials.gov NCT04221789; https://clinicaltrials.gov/ct2/show/NCT04221789. International Registered Report Identifier (IRRID) DERR1-10.2196/28094" @default.
• W3141650554 created "2021-04-13" @default.
• W3141650554 creator A5006023542 @default.
• W3141650554 creator A5010237268 @default.
• W3141650554 creator A5010851361 @default.
• W3141650554 creator A5022846180 @default.
• W3141650554 creator A5026718720 @default.
• W3141650554 creator A5028531772 @default.
• W3141650554 creator A5044126190 @default.
• W3141650554 creator A5047774251 @default.
• W3141650554 creator A5071401025 @default.
• W3141650554 creator A5073321562 @default.
• W3141650554 date "2021-06-21" @default.
• W3141650554 modified "2023-10-16" @default.
• W3141650554 title "Mobile Tuberculosis Treatment Support Tools to Increase Treatment Success in Patients with Tuberculosis in Argentina: Protocol for a Randomized Controlled Trial" @default.
• W3141650554 cites W1558780294 @default.
• W3141650554 cites W1748592323 @default.
• W3141650554 cites W1978624695 @default.
• W3141650554 cites W1987544613 @default.
• W3141650554 cites W1988611386 @default.
• W3141650554 cites W2020287371 @default.
• W3141650554 cites W2021282528 @default.
• W3141650554 cites W2039555502 @default.
• W3141650554 cites W2068658605 @default.
• W3141650554 cites W2072181779 @default.
• W3141650554 cites W2076146503 @default.
• W3141650554 cites W2100810884 @default.
• W3141650554 cites W2105242647 @default.
• W3141650554 cites W2109031474 @default.
• W3141650554 cites W2114993263 @default.
• W3141650554 cites W2119700561 @default.
• W3141650554 cites W2122838852 @default.
• W3141650554 cites W2144010669 @default.
• W3141650554 cites W2150104072 @default.
• W3141650554 cites W2155441883 @default.
• W3141650554 cites W2169796043 @default.
• W3141650554 cites W2237071560 @default.
• W3141650554 cites W2300935853 @default.
• W3141650554 cites W2393830291 @default.
• W3141650554 cites W2441617215 @default.
• W3141650554 cites W2466022814 @default.
• W3141650554 cites W2588254203 @default.
• W3141650554 cites W2782452598 @default.
• W3141650554 cites W2791919557 @default.
• W3141650554 cites W2981034945 @default.
• W3141650554 cites W3010736686 @default.
• W3141650554 cites W3012111492 @default.
• W3141650554 cites W3016659462 @default.
• W3141650554 cites W4210749876 @default.
• W3141650554 cites W4251315469 @default.
• W3141650554 cites W79229537 @default.
• W3141650554 doi "https://doi.org/10.2196/28094" @default.
• W3141650554 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8277351" @default.
• W3141650554 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34152281" @default.
• W3141650554 hasPublicationYear "2021" @default.
• W3141650554 type Work @default.
• W3141650554 sameAs 3141650554 @default.
• W3141650554 citedByCount "2" @default.
• W3141650554 countsByYear W31416505542022 @default.
• W3141650554 countsByYear W31416505542023 @default.
• W3141650554 crossrefType "journal-article" @default.
• W3141650554 hasAuthorship W3141650554A5006023542 @default.
• W3141650554 hasAuthorship W3141650554A5010237268 @default.
• W3141650554 hasAuthorship W3141650554A5010851361 @default.
• W3141650554 hasAuthorship W3141650554A5022846180 @default.
• W3141650554 hasAuthorship W3141650554A5026718720 @default.
• W3141650554 hasAuthorship W3141650554A5028531772 @default.
• W3141650554 hasAuthorship W3141650554A5044126190 @default.
• W3141650554 hasAuthorship W3141650554A5047774251 @default.
• W3141650554 hasAuthorship W3141650554A5071401025 @default.
• W3141650554 hasAuthorship W3141650554A5073321562 @default.
• W3141650554 hasBestOaLocation W31416505541 @default.
• W3141650554 hasConcept C107457646 @default.
• W3141650554 hasConcept C141071460 @default.
• W3141650554 hasConcept C142724271 @default.
• W3141650554 hasConcept C159110408 @default.
• W3141650554 hasConcept C168563851 @default.
• W3141650554 hasConcept C170130773 @default.
• W3141650554 hasConcept C27415008 @default.
• W3141650554 hasConcept C2780665704 @default.
• W3141650554 hasConcept C2781069245 @default.
• W3141650554 hasConcept C41008148 @default.
• W3141650554 hasConcept C512399662 @default.
• W3141650554 hasConcept C535046627 @default.
• W3141650554 hasConcept C71924100 @default.
• W3141650554 hasConceptScore W3141650554C107457646 @default.
• W3141650554 hasConceptScore W3141650554C141071460 @default.
• W3141650554 hasConceptScore W3141650554C142724271 @default.
• W3141650554 hasConceptScore W3141650554C159110408 @default.
• W3141650554 hasConceptScore W3141650554C168563851 @default.
• W3141650554 hasConceptScore W3141650554C170130773 @default.
• W3141650554 hasConceptScore W3141650554C27415008 @default.
• W3141650554 hasConceptScore W3141650554C2780665704 @default.
• W3141650554 hasConceptScore W3141650554C2781069245 @default.
• W3141650554 hasConceptScore W3141650554C41008148 @default.
• W3141650554 hasConceptScore W3141650554C512399662 @default.
• W3141650554 hasConceptScore W3141650554C535046627 @default.
• W3141650554 hasConceptScore W3141650554C71924100 @default.

• next